Agouron Pharmaceuticals
A Pfizer Company
ATAC DDC Liaisons: Ken Fornataro, Tom Gegeny, Cathy Olufs
COMPANY INFORMATION
MEETING AND CALL NOTES
Todd Mills
National Account Manager, HIV Relations
Pfizer Global Pharmaceuticals
10777 Science Center Drive
San Diego, CA 92121-1111
Phone: (858) 622-7674
Fax: (858) 526-4551
Email: [email protected]
NOTE: Pfizer manufactures several drugs
often used by people with HIV, including the following (links
to individual product web sites):
Diflucan® (fluconazole)
Lipitor® (atorvastatin calcium)
Viagra® (sildenafil citrate)
Viracept® (nelfinavir mesylate)
Vfend® (voriconazole)
Zithromax® (azithromycin)
Zoloft® (sertraline HCL)
1. FDA-Approved Products:
Non-nucleoside reverse transcriptase inhibitor: delavirdine
(Rescriptor®)
Protease inhibitor: nelfinavir (Viracept®)
2. Products in Clinical Trials:
Non-nucleoside reverse transcriptase inhibitor: Capravirine
(Phase II)
CCR5 Inhibitor: UK-427,857 (Phase I)
Web pages:
NOTE: Research and development activities are conducted by Pfizer Global Research and Development, with facilities in La Jolla, CA; and Sandwich, UK. Post-approval activities (marketing and community relations) are conducted by Agouron Pharmaceuticals, with offices in La Jolla, CA.
Pfizer Global Research Group
Peter Hawley, MD Director, Anti-Infectives (La Jolla)
Chris Hitchcock, PhD Senior Director, Exploratory Development
(Sandwich)
Anne Jenkins Lead Project Manager, Global Project Management(Sandwich)
Agouron Pharmaceuticals
Elaine Daniels, MD, PhD Senior Director, Team Leader, Medical
Affairs
Ann Kolokathis, MD Vice President, Medical Affairs
Bob Mischler Director, New Product Development
Richard Ogden, PhD Senior Director, Scientific Development
Carolyn Petersen, MD Medical Research Director
John Poyhonen Vice President, Marketing
Ron Roberts Senior Director, Government Affairs